The American Heart Association has acquired program assets of the Cardiometabolic Center Alliance (CMCA), a collaborative focused on integrated care for cardiovascular, kidney, and metabolic health. The move, announced October 1, 2025, aims to combine resources and expertise to expand a care model that treats conditions such as Type 2 diabetes, pre-diabetes, and related cardiovascular diseases together rather than separately.
The CMCA, founded by Saint Luke’s Mid America Heart Institute in Kansas City, Mo., under the medical direction of Mikhail Kosiborod, M.D., began as an initiative to reshape cardiometabolic care. Its model, developed through the Saint Luke’s Michael and Marlys Haverty Cardiometabolic Center of Excellence, uses a team-based approach tailored to each patient. The model has been recognized in top medical journals, and CMCA members have observed statistically significant improvements in quality of care and clinical outcomes.
Melissa Magwire, RN, MSN, CDCES, program director of the CMCA, said in a statement, “Since launching the Cardiometabolic Center Alliance in 2020, we have witnessed an increasing demand to expand our collaborative team-based care model. By working with the American Heart Association, we now have the opportunity to expand and scale these efforts, enabling us to help even more people live longer, healthier lives.”
The acquisition will enhance the Heart Association’s development of a Cardiovascular-Kidney-Metabolic Center of Excellence certification program. The CMCA membership includes clinical protocols, materials, program support for 22 cardiometabolic centers, and a five-year longitudinal dataset of patient-level cardiometabolic data. The Heart Association will lead program development, implementation, and clinical support for existing CMCA members.
Mariell Jessup, M.D., FAHA, Chief Science & Medical Officer of the American Heart Association, said, “The American Heart Association is proud to carry the torch forward toward integrated, patient-centered care for people with cardiovascular, kidney and metabolic conditions. This is a rare opportunity to optimize the synergy between the two organizations and combine efforts and resources for greater impact.”
The CMCA leadership will transition to committee and staff roles at the American Heart Association. The collaborative had already established a relationship with the Heart Association based on a shared mission of comprehensive risk reduction and improving quality of care.
Additional information about the American Heart Association can be found at heart.org. The original release is available at www.newmediawire.com.
